PROTHROMBINEX-VF human prothrombin complex powder for injection vial and diluent vial Australia - English - Department of Health (Therapeutic Goods Administration)

prothrombinex-vf human prothrombin complex powder for injection vial and diluent vial

csl behring australia pty ltd - factor ix, quantity: 500 iu; factor x, quantity: 500 iu; factor ii, quantity: 500 iu - injection, diluent for - excipient ingredients: water for injections - prothrombinex-vf is indicated in - treatment and perioperative prophylaxis of bleeding in acquired deficiency of prothrombin complex factors, such as deficiency caused by treatment with vitamin k antagonists, or in case of overdose of vitamin k antagonists, when rapid correction of the deficiency is required. - treatment and prophylaxis of bleeding in patients with single or multiple congenital deficiency of factor ix, ii or x when purified specific coagulation factor product is not available (see precautions).

BERIPLEX P/N human prothrombin complex 1000 IU powder for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

beriplex p/n human prothrombin complex 1000 iu powder for injection vial

csl behring australia pty ltd - water for injections, quantity: 40 ml - injection, solution - excipient ingredients: - treatment and perioperative prophylaxis of bleedings in acquired deficiency of the prothrombin complex coagulation factors, such as deficiency caused by treatment with vitamin k antagonists, or in case of overdose of vitamin k antagonists, when rapid correction of the deficiency is required.

BERIPLEX P/N human prothrombin complex 500 IU powder for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

beriplex p/n human prothrombin complex 500 iu powder for injection vial

csl behring australia pty ltd - water for injections, quantity: 20 ml - injection, solution - excipient ingredients: - treatment and perioperative prophylaxis of bleedings in acquired deficiency of the prothrombin complex coagulation factors, such as deficiency caused by treatment with vitamin k antagonists, or in case of overdose of vitamin k antagonists, when rapid correction of the deficiency is required.

CSL NEW ZEALAND Prothrombinex-VF Human Prothrombin Complex 500 IU Powder for injection Australia - English - Department of Health (Therapeutic Goods Administration)

csl new zealand prothrombinex-vf human prothrombin complex 500 iu powder for injection

csl behring australia pty ltd - factor ix, quantity: 500 iu; factor x, quantity: 500 iu; factor ii, quantity: 500 iu - injection, diluent for - excipient ingredients: water for injections - prothrombinex-vf is indicated in the prophylaxis and treatment of bleeding in patients with single or multiple congenital deficiency of factor ix, ii or x and in patients with single or multiple acquired prothrombin complex factor deficiency requiring partial or complete reversal (e.g. reversal of warfarin anti-coagulant therapy). because of the potential risk of prothrombinex-vf induced thrombosis, prothrombinex-vf should not be used for prophylaxis or treatment of haemorrhage in patients with haemophilia b if a highly-purified factor ix preparation is available.

CSL HONG KONG PROTHROMBINEX-VF Human prothrombin complex, powder for injection Australia - English - Department of Health (Therapeutic Goods Administration)

csl hong kong prothrombinex-vf human prothrombin complex, powder for injection

csl behring australia pty ltd - factor x, quantity: 500 iu; factor ix, quantity: 500 iu; factor ii, quantity: 500 iu - injection, diluent for - excipient ingredients: water for injections - prothrombinex?-vf is indicated in: ?treatment and perioperative prophylaxis of bleeding in acquired deficiency of prothrombin complex factors, such as deficiency caused by treatment with vitamin k antagonists, or in case of overdose of vitamin k antagonists, when rapid correction of the deficiency is required. ?treatment and prophylaxis of bleeding in patients with single or multiple congenital deficiency of factor ix, ii or x when purified specific coagulation factor product is not available.

Human Albumin = Human bioplazma Solution For Infusion Kenya - English - Pharmacy and Poisons Board

human albumin = human bioplazma solution for infusion

human bioplazma llc h-2100 godollo transics milhaly ut 80hungary - human albumin - solution for infusion - 20%human albumin - blood substitutes and plasma protein fractions

VeraSeal solutions for sealant 2 mL (Human fibrinogen 80 mg/mL syringe 1 mL / Human thrombin 500 IU/mL syringe 1 mL) Australia - English - Department of Health (Therapeutic Goods Administration)

veraseal solutions for sealant 2 ml (human fibrinogen 80 mg/ml syringe 1 ml / human thrombin 500 iu/ml syringe 1 ml)

grifols australia pty ltd - human thrombin, quantity: 500 iu/ml - application - excipient ingredients: - veraseal is used as supportive treatment in adults where standard surgical techniques are insufficient, for improvement of hemostasis.

VeraSeal solutions for sealant 10 mL (Human fibrinogen 80 mg/mL syringe 5 ml / Human thrombin 500 IU/mL syringe 5 ml) Australia - English - Department of Health (Therapeutic Goods Administration)

veraseal solutions for sealant 10 ml (human fibrinogen 80 mg/ml syringe 5 ml / human thrombin 500 iu/ml syringe 5 ml)

grifols australia pty ltd - human thrombin, quantity: 500 iu/ml - application - excipient ingredients: - veraseal is used as supportive treatment in adults where standard surgical techniques are insufficient, for improvement of hemostasis.

VeraSeal solutions for sealant 4 mL (Human fibrinogen 80 mg/mL syringe 2 ml / Human thrombin 500 IU/mL syringe 2 ml) Australia - English - Department of Health (Therapeutic Goods Administration)

veraseal solutions for sealant 4 ml (human fibrinogen 80 mg/ml syringe 2 ml / human thrombin 500 iu/ml syringe 2 ml)

grifols australia pty ltd - human thrombin, quantity: 500 iu/ml - application - excipient ingredients: - veraseal is used as supportive treatment in adults where standard surgical techniques are insufficient, for improvement of hemostasis.

VeraSeal solutions for sealant 6 mL (Human fibrinogen 80 mg/mL syringe 3 ml / Human thrombin 500 IU/mL syringe 3 ml) Australia - English - Department of Health (Therapeutic Goods Administration)

veraseal solutions for sealant 6 ml (human fibrinogen 80 mg/ml syringe 3 ml / human thrombin 500 iu/ml syringe 3 ml)

grifols australia pty ltd - human thrombin, quantity: 500 iu/ml - application - excipient ingredients: - veraseal is used as supportive treatment in adults where standard surgical techniques are insufficient, for improvement of hemostasis.